News

The American Journal of Managed Care3h
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...
Rheumatology Advisor7h
Brain MRI Study Uncovers Potential Small-Vessel Disease Burden in SSc
Patients with SSc vs controls showed a greater prevalence of WMH on brain MRIs, particularly in deep white matter regions.
Novartis Pharma AG: Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren's ...
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren’s ...